Latest / The Dales Report | Trade to Black
A Once-in-a-Century Shift in Mental Health | Trade to Black
On this episode of Trade to Black, presented by Flowhub, hosts Shadd Dales and Anthony Varrell sit down with Dan Karlin, Chief Medical Officer of Definium Therapeutics (NASDAQ: DFTX), to talk about where the company stands with DT-120, its pharmaceutically optimized LSD program for mental health disorders.Karlin walks through what the Trump administration’s April executive order supporting psychedelic research actually meant for the space, and why he sees it as validation for work Definium has been quietly building toward for over five years. The timing lines up with a bigger shift happening…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.